| Âîñïàëèòåëüíûå áîëåçíè öåíòðàëüíîé íåðâíîé ñèñòåìû (G00-G09) | |
| Áàêòåðèàëüíûé ìåíèíãèò, íå êëàññèôèöèðîâàííûé â äðóãèõ ðóáðèêàõ | |
| ÀÇÀÐÀÍ | HEMOFARM KONCERN A.D. |
| ÀÌÎÊÑÈÑÀЮ | ÁÈÎÕÈÌÈÊ ÎÀÎ |
| ÀÌÏÈÖÈËËÈÍ-ÀÊÎÑ | ÑÈÍÒÅÇ ÎÀÎ |
| ÁÀÊËÎÔÅÍ | POLPHARMA S.A. |
| ÁÈÑÅÏÒÎË | PHARMACEUTICAL WORKS POLFA IN PABIANICE J.S. Co. |
| ÂÈÔÅÐÎÍ® | ÔÅÐÎÍ ÎÎÎ |
| ÊËÀÔÎÐÀÍ | Laboratoires ROUSSEL-DIAMANT |
| ÊËÈÎÍ | ÃÅÄÅÎÍ ÐÈÕÒÅÐ-ÐÓÑ ÇÀÎ |
| ÌÀÊÑÈÏÈÌ | BRISTOL-MYERS SQUIBB S.r.L. |
| ÌÅÐÎÍÅÌ | SUMITOMO PHARMACEUTICALS Co Ltd. |
| ÌÅÒÐÎÍÈÄÀÇÎË-ÀÊÎÑ | ÑÈÍÒÅÇ ÎÀÎ |
| ÎÔËÎÊÑÀÖÈÍ-ÀÊÎÑ | ÑÈÍÒÅÇ ÎÀÎ |
| ÎÔËÎÊÑÀÖÈÍ | ÑÈÍÒÅÇ ÎÀÎ |
| ÑÅËÅÌÈÖÈÍ | MEDOCHEMIE Ltd. |
| ÑÓËÜÏÅÐÀÇÎÍ | PFIZER |
| ÑÓËÜÒÀÑÈÍ® | ÑÈÍÒÅÇ ÎÀÎ |
| ÒÐÈÕÎÏÎË | POLPHARMA S.A. |
| ÔÎÐÒÓÌ | GlaxoSmithKline S.p.A. |
| ÖÅÔÀÒ® | ÑÈÍÒÅÇ ÎÀÎ |
| ÖÅÔÎÑÈÍ® | ÑÈÍÒÅÇ ÎÀÎ |
| ÖÅÔÒÀÇÈÄÈÌ-ÀÊÎÑ | ÑÈÍÒÅÇ ÎÀÎ |
| ÖÅÔÒÐÈÀÊÑÎÍ-ÀÊÎÑ | ÑÈÍÒÅÇ ÎÀÎ |